![](/img/cover-not-exists.png)
A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL® [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson's disease
Snow, Barry, Mulroy, Eoin, Bok, Arnold, Simpson, Mark, Smith, Andrew, Taylor, Kenneth, Lockhart, Michelle, Lam, BB Janice, Frampton, Christopher, Schweder, Patrick, Chen, Benson, Finucane, Gregory, McLanguage:
english
Journal:
Parkinsonism & Related Disorders
DOI:
10.1016/j.parkreldis.2018.11.015
Date:
November, 2018
File:
PDF, 968 KB
english, 2018